New video from Crystec highlights mSAS technology

Published: 9-Aug-2017
Manufacturing

mSAS particle engineering versus conventional micronisation


The video is a visual demonstration of the advantages that Crystec’s mSAS (modified supercritical antisolvent) platform has compared with conventional technologies, and the impact that such processing can have on the ease of subsequent manufacturing, as well as product performance.


For more information on how mSAS can accelerate development and enhance the performance of medicines, please visit www.crystecpharma.com.

  • Companies:
  • Crystec Pharma
See more

You may also like

Distribution

Manufacturing Chemist LIVE 2022 in review (part II)

Read more
Taking a front row seat during the two-day pharmaceutical conference in Birmingham, UK, Dr Kevin Robinson reports on what’s new, emerging and exciting in the world of drug delivery and beyond

Trending Articles

  1. Thermo Fisher Scientific highlights its new accelerator drug development solutions at CPHI Frankfurt 2025 The company has also announced a collaboration with OpenAI as well as a new digital toolbox, OSDPredict, which combines AI and machine learning models to predict formulation behaviour in small-molecule development
  2. Merck Life Science announces closure of Arklow facility Merck has said it will close the plant in Co Wicklow, Ireland, by the end of 2028, with the loss of 100 jobs
  3. Aseptic spray drying: Transforming biotherapeutics for a new era With interest in aseptic spray drying on the rise in the pharmaceutical industry, Dr Kevin Robinson spoke to GEA’s David Costes about how the company is combining process, engineering and technological expertise with market insights to provide a safe, reliable and high-performance technology for advanced biotherapeutic powder applications
  4. Hovione completes $100m investment cycle for expansion of US manufacturing campus The investment into the New Jersey facility will more than double capacity for spray drying
  5. What to expect from a regulatory inspection NSF’s expert guide outlines key expectations, common pitfalls and strategies for lasting inspection readiness

You may also like

Distribution

Manufacturing Chemist LIVE 2022 in review (part II)

Taking a front row seat during the two-day pharmaceutical conference in Birmingham, UK, Dr Kevin Robinson reports on what’s new, emerging and exciting in the world of drug delivery and beyond
Manufacturing

Crystec wins Contract Services and Outsourcing Award at CPhI Awards

Crystec are delighted to have been awarded the CPhI Excellence in Pharma Award for Contract Services and Outsourcing
Manufacturing

Frontline innovation: dispatches from the show floor at CPHI Frankfurt (part III)

The third instalment from the CPHI Frankfurt show floor explores practical approaches and fresh perspectives on scale-up, tech transfer, and manufacturing innovation across the pharmaceutical sector
Manufacturing

Streamlining bioconjugation for next-generation ADC development

Abzena’s proprietary ThioBridge™ technology delivers precision, scalability, and enhanced stability for antibody-drug conjugates
Manufacturing

OPTIMA machinery USA Corporation marks 40 years of growth and innovation in the US

OPTIMA machinery USA Corporation, a subsidiary of the German-based OPTIMA Packaging Group, is celebrating 40 years of successful operations in the United States
Manufacturing

How to execute a successful remediation strategy

NSF’s experts share guidance on building sustainable compliance and avoiding quick fixes
Manufacturing

How to optimise your quality culture and maturity for success

NSF outlines how aligning culture, leadership and systems can strengthen compliance and performance
Subscribe now